[go: up one dir, main page]

AU2002311176A1 - Chfr protein-catalyzed polyubiquitination of aurora kinase a and aurora kinase b - Google Patents

Chfr protein-catalyzed polyubiquitination of aurora kinase a and aurora kinase b

Info

Publication number
AU2002311176A1
AU2002311176A1 AU2002311176A AU2002311176A AU2002311176A1 AU 2002311176 A1 AU2002311176 A1 AU 2002311176A1 AU 2002311176 A AU2002311176 A AU 2002311176A AU 2002311176 A AU2002311176 A AU 2002311176A AU 2002311176 A1 AU2002311176 A1 AU 2002311176A1
Authority
AU
Australia
Prior art keywords
aurora kinase
polyubiquitination
catalyzed
chfr protein
chfr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002311176A
Other languages
English (en)
Inventor
Hideyo Yasuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AXIA BIOSCIENCES Inc
Original Assignee
AXIA BIOSCIENCES Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AXIA BIOSCIENCES Inc filed Critical AXIA BIOSCIENCES Inc
Publication of AU2002311176A1 publication Critical patent/AU2002311176A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Enzymes And Modification Thereof (AREA)
AU2002311176A 2002-06-12 2002-06-12 Chfr protein-catalyzed polyubiquitination of aurora kinase a and aurora kinase b Abandoned AU2002311176A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2002/005828 WO2003107002A1 (fr) 2002-06-12 2002-06-12 Polyubiquitination catalysee par une proteine chfr de aurora kinase a et aurora kinase b

Publications (1)

Publication Number Publication Date
AU2002311176A1 true AU2002311176A1 (en) 2003-12-31

Family

ID=29727342

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002311176A Abandoned AU2002311176A1 (en) 2002-06-12 2002-06-12 Chfr protein-catalyzed polyubiquitination of aurora kinase a and aurora kinase b

Country Status (2)

Country Link
AU (1) AU2002311176A1 (fr)
WO (1) WO2003107002A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007514759A (ja) 2003-12-19 2007-06-07 タケダ サン ディエゴ インコーポレイテッド キナーゼ阻害剤
JP2008510734A (ja) 2004-08-18 2008-04-10 タケダ サン ディエゴ インコーポレイテッド キナーゼ阻害剤
DE602005023333D1 (de) 2004-10-15 2010-10-14 Takeda Pharmaceutical Kinaseinhibitoren
US8119655B2 (en) 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
BRPI0719883A2 (pt) 2006-10-09 2015-05-05 Takeda Pharmaceutical Inibidores de quinase

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7176293B1 (en) * 1999-07-29 2007-02-13 The Wistar Institute Of Anatomy And Biology Compositions and methods to enhance sensitivity of cancer cells to mitotic stress

Also Published As

Publication number Publication date
WO2003107002A1 (fr) 2003-12-24

Similar Documents

Publication Publication Date Title
AU2003304426A1 (en) Quorum sensing and biofilm formation
AU2003225668A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003213673A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003259749A1 (en) 3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors
AU2003261974A1 (en) Amine compounds and use thereof
AU2003249663A1 (en) Summarization of a visual recording
AU2003226094A1 (en) Compounds and methods
AU2003259438A1 (en) Di and trifluoro-triazolo-pyridines anti-inflammatory compounds
AU2003220437A1 (en) Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
AU2003270883A1 (en) Detection of preselected data
AU2003263323A1 (en) Quinazolinone derivatives
AUPS328402A0 (en) Writing of photo-induced structures
AU2003210983A1 (en) Kinase inhibitors and methods of use thereof
EP1572950A3 (fr) Composes domaine unique associes tdf et analogues de ceux-ci
AU2002311176A1 (en) Chfr protein-catalyzed polyubiquitination of aurora kinase a and aurora kinase b
AU2003212457A1 (en) Derivatives of epothilone b and d and synthesis thereof
AU2003281691A1 (en) Furoisoquinoline derivative and use thereof
AU2003287802A1 (en) Palpometer and methods of use thereof
AU2003231827A1 (en) Pseudo-tissues and uses thereof
AU2003226511A1 (en) Soft screen workbook
AU2003296871A1 (en) Point feeder and use of point feeder
AU2003302173A1 (en) Spirotetrathiocarbamates and spirooxothiocarbamates
AU2003215379A1 (en) Substituted pyrimidinones and pyrimidinthiones
AU2003255803A1 (en) Quinazolinone derivatives
AU2003276752A1 (en) Multiple domain tdf-related compounds and analogs thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase